DeutschNewstral
Article
bizjournals.com on 2022-02-06 03:33
RTP gene therapy firm's new CEO is industry veteran with IPO experience
Related news
- RTP gene therapy firm's new CEO is industry veteran with IPO experiencebizjournals.com
- CEO details plan for gene therapy firm's $125M RTP expansionbizjournals.com
- Gene therapy firm expanding in RTP bulks up C-suite with industry veteranbizjournals.com
- Philadelphia gene therapy startup plans $125M IPObizjournals.com
- RTP firm accelerating gene therapy adds $270M to support growthbizjournals.com
- RTP newcomer raises $100M to advance gene therapy platformbizjournals.com
- AveXis gene therapy firm in Dallas files for $115M IPObizjournals.com
- The Petri Dish: An IPO revisited and Sarepta's gene therapybizjournals.com
- Gene therapy company Audentes shoots for $86M IPObizjournals.com
- Penn gene therapy spinout exceeds projections with $216M IPObizjournals.com
- Could this gene therapy company be the next IPO? (Video)bizjournals.com
- $81M raise for gene therapy firm in RTP will help double headcount, CEO saysbizjournals.com
- WDrug giant Bayer acquires RTP gene therapy startup AskBio for as much as $4Bwraltechwire.com
- WBiogen picks RTP for $200M gene therapy manufacturing center, scores of new jobswraltechwire.com
- Gene therapy firm expands operations in RTP as headcount reaches 100bizjournals.com
- WPfizer to build gene therapy facility in RTP, could add up to 120 scientists, staffwraltechwire.com
- Why an RTP gene therapy company just acquired a competing delivery technologybizjournals.com
- RTP firm combines subsidiary with Massachusetts company to boost gene therapy expertisebizjournals.com
- Voyager’s planned IPO will be a bellwether for both Mass. and gene therapybizjournals.com